share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thornberry Nancy

SEC announcement ·  May 3 16:28
Summary by Moomoo AI
Nancy Thornberry, associated with Vertex Pharmaceuticals Inc. [VRTX], completed a transaction on May 1, 2024, acquiring 501 shares of common stock at no cost. This grant transaction has increased Thornberry's direct holdings to a total of 1,637 shares in the company. The transaction, which was completed as a grant, award, or other acquisition, reflects a continued investment in the company by Thornberry.
Nancy Thornberry, associated with Vertex Pharmaceuticals Inc. [VRTX], completed a transaction on May 1, 2024, acquiring 501 shares of common stock at no cost. This grant transaction has increased Thornberry's direct holdings to a total of 1,637 shares in the company. The transaction, which was completed as a grant, award, or other acquisition, reflects a continued investment in the company by Thornberry.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more